Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Expert Review of Cardiovascular Therapy
|
August 8, 2025
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines
Göran Walldius
Expert Review of Cardiovascular Therapy
|
August 8, 2025
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines
Göran Walldius
Lakartidningen
|
April 23, 2004
[Apolipoproteins are new and better risk indicators of myocardial infarction]
Göran Walldius, Ingmar Jungner
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2007
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy
Göran Walldius, Ingmar Jungner
Current Opinion in Cardiology
|
June 9, 2007
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
Göran Walldius, Ingmar Jungner
Journal of Hepatology
|
July 5, 2020
Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
Hannes Hagström, Mats Talbäck, Anna Andreasson, et al.
Gastroenterology
|
September 30, 2019
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hannes Hagström, Mats Talbäck, Anna Andreasson, et al.
Annals of Medicine
|
May 19, 2011
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Atherosclerosis
|
September 17, 2010
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Annals of Medicine
|
August 7, 2009
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Expert Review of Cardiovascular Therapy
|
August 8, 2025
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines
Göran Walldius
Expert Review of Cardiovascular Therapy
|
August 8, 2025
High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines
Göran Walldius
Lakartidningen
|
April 23, 2004
[Apolipoproteins are new and better risk indicators of myocardial infarction]
Göran Walldius, Ingmar Jungner
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 17, 2007
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy
Göran Walldius, Ingmar Jungner
Current Opinion in Cardiology
|
June 9, 2007
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke
Göran Walldius, Ingmar Jungner
Journal of Hepatology
|
July 5, 2020
Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
Hannes Hagström, Mats Talbäck, Anna Andreasson, et al.
Gastroenterology
|
September 30, 2019
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hannes Hagström, Mats Talbäck, Anna Andreasson, et al.
Annals of Medicine
|
May 19, 2011
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Atherosclerosis
|
September 17, 2010
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Annals of Medicine
|
August 7, 2009
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Page
of 8